Clinical Trial Update: Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction [Phase 2]

View source ↗

Summary

Exploratory dose-ranging Phase 2 trial update for APH-1501 in opioid addiction, status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• APH-1501

Snippet

Sponsor: Aphios | Conditions: Addiction, Opioid Dependence | Phase 2 | Status: UNKNOWN